68Ga-PSMA-11 PET/CT versus 68Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis
R Huang, Y Li, H Wu, B Liu, X Zhang, Z Zhang - Frontiers in Oncology, 2023 - frontiersin.org
Purpose Our aim was to conduct a meta-analysis and systematic review in order to compare
the diagnostic efficacy of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in patients …
the diagnostic efficacy of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in patients …
Bone metastases are measurable: the role of whole-body MRI and positron emission tomography
DE Oprea-Lager, MCF Cysouw, R Boellaard… - Frontiers in …, 2021 - frontiersin.org
Metastatic tumor deposits in bone marrow elicit differential bone responses that vary with the
type of malignancy. This results in either sclerotic, lytic, or mixed bone lesions, which can …
type of malignancy. This results in either sclerotic, lytic, or mixed bone lesions, which can …
Applications of PET/MRI in abdominopelvic oncology
SJ Galgano, CE Calderone, C Xie, EN Smith… - Radiographics, 2021 - pubs.rsna.org
With PET/MRI, the strengths of PET and MRI are combined to allow simultaneous image
acquisition and near-perfect image coregistration. MRI is increasingly being used for staging …
acquisition and near-perfect image coregistration. MRI is increasingly being used for staging …
Management of patients with recurrent and metachronous oligometastatic prostate cancer in the era of PSMA PET
Simple Summary Prostate-specific membrane antigen positron emission tomography (PSMA
PET) is a modern imaging modality used in the management of patients with prostate cancer …
PET) is a modern imaging modality used in the management of patients with prostate cancer …
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
Oligometastatic prostate cancer (OMPC) has been proposed as an intermediary state
between localised disease and widespread metastases, with varying definitions including 1 …
between localised disease and widespread metastases, with varying definitions including 1 …
Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology …
Abstract Objective To assess European Association of Urology (EAU) risk groups for
biochemical recurrence (BCR) of prostate cancer relative to prostate‐specific membrane …
biochemical recurrence (BCR) of prostate cancer relative to prostate‐specific membrane …
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A review
Abstract Background Oligometastatic prostate cancer (OMPCa) is emerging as a transitional
disease state between localized and polymetastatic disease. This review will assess the …
disease state between localized and polymetastatic disease. This review will assess the …
Detection rate of PSMA PET using different ligands in men with biochemical recurrent prostate cancer following radical treatment: a systematic review and meta …
Background Despite the acknowledged diagnostic detection rate of prostate-specific
membrane antigen (PSMA) positron emission tomography (PET) imaging in prostate cancer …
membrane antigen (PSMA) positron emission tomography (PET) imaging in prostate cancer …
Added value of [18F] PSMA‐1007 PET/CT and PET/MRI in patients with biochemically recurrent prostate cancer: impact on detection rates and clinical management
BS Abrahamsen, T Tandstad… - Journal of Magnetic …, 2024 - Wiley Online Library
Background Prostate‐specific membrane antigen (PSMA) positron emission tomography
(PET) can change management in a large fraction of patients with biochemically recurrent …
(PET) can change management in a large fraction of patients with biochemically recurrent …
Role of 68Ga and 18F PSMA PET/CT and PET/MRI in biochemical recurrence of prostate cancer: a systematic review of prospective studies
Objective To systematically review the prospective literature on the role of 68 Ga and 18 F
PSMA PET/CT and PET/MRI as a tool for functional imaging in prostate cancer biochemical …
PSMA PET/CT and PET/MRI as a tool for functional imaging in prostate cancer biochemical …